Search
for
Sort by
Research 30 of 1000+
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Evaluation of Atherogenic Indexes in Patients With Lichen Planopilaris: A Case-Control Study
- Effect of an oral probiotic formula on scalp and facial skin condition, glucose, and lipid metabolism
- Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile
- Serum lipid profile and insulin resistance in women with polycystic ovary syndrome (PCOS)
- Effects of Abuse of Anabolic Androgenic Steroids on Iraqi Athletes
- Atherogenic index of plasma in non-obese women with androgenetic alopecia
- Review of Baricitinib in the Treatment of Alopecia Areata.
- The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome
- Dyslipidemia, hormonal profiles, and sleep characteristics in men with androgenetic alopecia: an analysis based on data from the EPISONO study
- The Impact of Obesity on the Metabolic Profile of Patients with Polycystic Ovary Syndrome
- ZWIĄZEK KLINICZNY I LABORATORYJNY ZESPOŁU METABOLICZNEGO Z CHODZENIEM I AKTYWNOŚCIAMI SPORTOWYMI NA ŚWIEŻYM POWIETRZU
- Cardiovascular Disease-Associated Skin Conditions
- Hair Minerals and Metabolic Health in Belgian Elementary School Girls
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Mendelian randomization analysis of the causal relationship between low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and androgenic alopecia
- Pattern of dyslipidemia among adult women with polycystic ovary syndrome in Port Harcourt, Nigeria
- Patients with vitiligo present fewer cardiovascular risk factors: results from a case–control study
- From Hairline to Lipid Line: Prevalence and Spectrum of Dyslipidemia in Patients with Androgenetic Alopecia – A Hospital-Based Study
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Association Between Premature Hair Greying and Metabolic Risk Factors: A Cross-sectional Study
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- Effect of finasteride on lipid profile in individuals with androgenetic alopecia
- Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome